SCHEMBL28030486

SCHEMBL28030486

NCC1CCNCC1.O=C(Cl)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
GBA1 P04062 1/20 0.46
NMT1 P30419 1/20 0.43
ITGB3 P05106 6/20 0.43
ITGA2B P08514 6/20 0.43
TSHR P16473 1/20 0.42
ITGAV P06756 1/20 0.42
HTR2C P28335 1/20 0.42
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HTR1A P08908 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28026009 0.86 ALDH1A1 (0.63) ALDH1A1NMT1TSHRHTR2CCYP2C19
SCHEMBL28330828 0.85 ALDH1A1 (0.58) ALDH1A1GBA1NMT1ITGB3ITGA2B
SCHEMBL28299374 0.85 ALDH1A1 (0.65) ALDH1A1GBA1NMT1TSHRHTR2C
SCHEMBL28823467 0.84 ALDH1A1 (0.56) ALDH1A1GBA1NMT1ITGB3ITGA2B
Piperazine SCHEMBL28816742 0.84 ALDH1A1 (0.79) ALDH1A1TSHRHTR2CSLC6A2SLC6A3
SCHEMBL28832220 0.84 ALDH1A1 (0.59) ALDH1A1NMT1TSHRHTR2CCYP2C19
SCHEMBL28049319 0.83 ALDH1A1 (0.63) ALDH1A1NMT1TSHRHTR2CCYP2C19
SCHEMBL28073264 0.81 ALDH1A1 (0.59) ALDH1A1NMT1TSHRHTR2CSMN1; SMN2
Pyrrolidine SCHEMBL28053584 0.81 ALDH1A1 (0.73) ALDH1A1TSHRHTR2CSLC6A2SLC6A3
Azetidine SCHEMBL28049251 0.81 ALDH1A1 (0.79) ALDH1A1TSHRHTR2CSLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102947285-B Sulfonamide derivatives as BCL-2-selective apoptosis inducers for the treatment of cancer and immune diseases ABBVIE (US) 2015-08-26 CN disclosed